Kyoto Pharmaceutical University
Kyoto, Kyoto
- UEI
- K29DPSBSDWZ1
- CAGE
- JSQS0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Japan, 〒607-8414 Kyoto, Yamashina Ward, Misasaginakauchichō, ５ 教育研究総合センター
- Website
- kyoto-phu.ac.jp
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Consumer Discretionary
- Diversified Consumer Services
- Education Services
- Education
- SIC code
- 82 Educational Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Oregon State University | R01GM132649 | $7,560 | |
| Oregon State University | R01GM132649 | $44,779 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Chubu University | Kasugai, Aichi | — |
| Stevenson University Inc. | MD | — |
| Long Island University | NY | 611310 Colleges, Universities, and Professional Schools |
| Medchemica Consultancy LIMITED | Newcastle-under-Lyme, England | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Nescom | Bangor, ME | 611310 Colleges, Universities, and Professional Schools |
About the company
Kyoto Pharmaceutical University is a private educational institution registered to receive federal grant awards from the U.S. government. As a foreign-owned entity, it is classified as a private university or college and a not-for-profit organization. The university specializes in pharmaceutical research and education, likely contributing expertise in drug development, medicinal chemistry, and related fields to federally funded research projects. Kyoto Pharmaceutical University has been registered in SAM.gov since March 19, 2020, with its current registration set to expire on November 27, 2024.
The university has been involved in at least three federal grant sub-awards, all related to a research project titled "Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands." This project appears to focus on studying how natural compounds affect protein production and secretion mechanisms within cells, particularly in relation to the translocon complex. In these sub-awards, Kyoto Pharmaceutical University has partnered with Oregon State University, which serves as the prime grantee. The repetition of this project across multiple sub-awards suggests an ongoing collaboration and a sustained research effort in this specific area of pharmaceutical science. Given the nature of the research, it is likely that these grants are funded by a federal agency such as the National Institutes of Health (NIH) or specifically the National Institute of General Medical Sciences (NIGMS), as indicated by the "GM" in one of the grant ID numbers.
Quick answers
Is Kyoto Pharmaceutical University registered in SAM.gov?
Yes. Kyoto Pharmaceutical University's SAM.gov registration is active through November 4, 2026.
On GovTribe
See Kyoto Pharmaceutical University's full federal record
- Similar vendors